Accenture and BioQ Team to Improve Speed and Quality of Regulatory Submissions for the Pharmaceutical and Medical Device Industries

NEW YORK and Carlsbad, CA, April 17 – Accenture, a leading global management and technology consultancy, and BioQ, a developer of state-of-the-art applications for navigating the regulatory approval process, today announced an alliance designed to improve the quality and timeliness of electronic submissions for the global pharmaceutical, biotechnology and medical device industries.

The alliance combines Accenture’s broad industry experience and leading-edge technology skills with BioQ’s expertise in creating interactive intelligent agent-based knowledge management, distance learning and collaboration tools. As part of the agreement, Accenture will receive an equity stake in BioQ and will become the premier provider of business integration services for the company’s software and content management tools.

Accenture and BioQ will jointly develop, market and implement solutions that support regulatory intelligence and knowledge management throughout the research and development and regulatory processes, with a focus on four key areas:

  1. improving quality, efficiency and compliance in the development of new medical products;
  2. streamlining development of submissions and preparation for interactions with regulators;
  3. enhancing the quality of information provided in regulatory submissions; and
  4. accelerating regulatory authority review and approval.

BioQ’s intelligent-agent-based system -- which gathers and delivers information, based on user profiles and user activities -- will offer interactive and user-friendly access to a wide and diverse selection of scientific, regulatory and other relevant pharmaceutical information. This highly advanced retrieval technique learns -- and responds to -- the knowledge professional’s specific information preferences, significantly improving speed and performance. BioQ’s software also offers access to internal databases and knowledge repositories, in addition to the typically searched external resources. In the future, BioQ will add distance learning and collaboration tools to support regulatory compliance and electronic submissions activities.

"Knowledge is not only the capability to access more data, but also the timeliness, delivery and relevance of the content that is available," said Mary Jo Veverka, partner, Accenture Global Pharmaceuticals & Medical Products practice. "While pharmaceutical companies and regulatory authorities have invested significant resources to convert paper submissions to electronic formats, it’s the added ability to address the quality and content within those submissions that positions this alliance to help bring better medicines to market more quickly."

“BioQ’s technology will help the industry deliver the best information at the right time, adding significant speed and quality to the drug development and approval process,” says Jeff Anderman, president and CEO of BioQ. “This alliance represents a revolutionary approach to how submissions are prepared and reviewed, enabling companies to reduce time-to-market and increase effective interaction with regulatory authorities.”

This new agreement adds to Accenture’s network of alliances aimed at providing the pharmaceutical industry with integrated solutions to improve the process of regulatory compliance. Accenture has recently formed an alliance with QUMAS, which is an enterprise compliance management solution for regulatory compliance.

About Accenture
Accenture is a $10.3 billion global management and technology consulting organization. The firm is reinventing itself to become the market maker, architect and builder of the new marketplace, bringing innovations to improve the way the world works and lives. More than 70,000 people in 46 countries deliver a wide range of specialized capabilities and solutions to clients across all industries. Under its strategy, the firm is building a network of businesses to meet the full range of client needs -- consulting, technology, outsourcing, alliances and venture capital. Accenture’s home page address is

About BioQ
BioQ ( combines regulatory and industry expertise, proprietary information and advanced technologies for managing knowledge to create software tools that allow pharmaceutical, biotechnology and medical device companies to expedite the regulatory process. Its solutions integrate knowledge management, process management and training to improve productivity and submit smart online applications in the upcoming FDA-required format. Overall, they help to automate business processes, foster collaborative communication and distribute current and relevant information throughout a highly regulated corporate structure. BioQ is located in Carlsbad, CA.